KemPharm
+$0.05 (+0.75%) Today
-$0.01 (-0.15%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KemPharm and other ETFs, options, and stocks.
About KMPH
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy.
CEO
Travis C. Mickle
Employees
22
Headquarters
Celebration, Florida
Founded
2006
KMPH Key Statistics
Market cap
236.64M
Price-Earnings ratio
—
Dividend yield
—
Average volume
584.00K
High today
$6.84
Low today
$6.43
Open price
$6.55
Volume
328.63K
52 Week high
$18.15
52 Week low
$5.86
KMPH Earnings
-$1.61
-$1.00
-$0.39
$0.22
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
—